EUVIMEDEUVIMED entdecken
Crossref

Correlation Between Statin Use and Symptomatic Venous Thromboembolism Incidence in Patients With Ankle Fracture: A Machine Learning Approach

Nour Nassour iD, Bardiya Akhbari, Noopur Ranganathan, Ahmed Tawakol, Rachel P Rosovsky, Daniel Guss, Christopher W DiGiovanni, Soheil Ashkani-Esfahani

Foot & Ankle Specialist · 2024

DOI: 10.1177/19386400231207692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Foot & Ankle Specialist, 2024. Verfasst von Nour Nassour und 7 weiteren Autor:innen. Beteiligte Einrichtung: Foot & Ankle Research and Innovation Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, M…. Hauptthemen laut MEDLINE: Ankle Fractures, Venous Thromboembolism, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Machine Learning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: American Orthopaedic Foot and Ankle Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Identifying factors that correlate with the incidence of venous thromboembolism (VTE) has the potential to improve VTE prevention and positively influence decision-making regarding prophylaxis. In this study, we aimed to investigate the correlation between statin consumption and the incidence of VTE in patients who sustained an ankle fracture.

Methods

In this retrospective, case-controlled study, cases were those who developed VTE and controls were those who had no VTE, and the ratio was 1:4. Patients’ demographics, history of hyperlipidemia, and reported statins use were obtained. A random forest classifier (RFC) model was used to predict whether statin consumers were at risk of VTE after ankle fracture regardless of VTE prophylaxis administration based on statin consumption, body mass index (BMI), age, and biological sex Results Of the 1175 patients with ankle fractures, 238 had confirmed VTE (case group), and 937 had no symptomatic VTE (control group; ratio 1:4). Fifty (21%) cases and 407 (43%) controls were on a statin. Statin users had a significantly lower incidence of VTE after ankle fracture, odds ratio (OR) = 0.35, 95% CI: 0.25, 0.49, P < .001. Our model showed an area under the receiving operator curve (AUROC) of 78%, a sensitivity of 73%, and a specificity of 83% in predicting the risk of VTE. The importance of the predictors of VTE, other than the use of statins (model importance = 0.1), were age (model importance of 0.72), BMI (model importance of 0.24), and biological sex (model importance of 0.02).

Conclusion

Statins were significantly associated with a lower rate of VTE in our population of patients who sustained an ankle fracture. Levels of Evidence: 3

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ankle FracturesVenous ThromboembolismHydroxymethylglutaryl-CoA Reductase InhibitorsMachine LearningHumansRetrospective StudiesMaleFemaleIncidenceMiddle AgedCase-Control StudiesAgedAdultRisk FactorsRisk Assessment

Stichwörter der Autor:innen

ankle fracturedeep vein thrombosisfoot and ankle fracturelipid-lowering agentspostoperative complicationspulmonary embolismstatinsthromboembolismvenous thromboembolism prophylaxis

Substanzen

Hydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Foot & Ankle Research and Innovation Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
  • Division of Cardiology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Division of Hematology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Foot and Ankle Division, Department of Orthopaedic Surgery, Massachusetts General Hospital, Newton Wellesley Hospital, Harvard Medical School, Boston, Massachusetts.

ORCID-Profile: Nour Nassour

Förderung

  • American Orthopaedic Foot and Ankle Society

Zitieren

APA

Nassour, N., Akhbari, B., Ranganathan, N., Tawakol, A., Rosovsky, R. P., Guss, D., DiGiovanni, C. W., & Ashkani-Esfahani, S. (2024). Correlation Between Statin Use and Symptomatic Venous Thromboembolism Incidence in Patients With Ankle Fracture: A Machine Learning Approach. Foot & Ankle Specialist. https://doi.org/10.1177/19386400231207692

Vancouver

Nassour N, Akhbari B, Ranganathan N, Tawakol A, Rosovsky RP, Guss D, et al. Correlation Between Statin Use and Symptomatic Venous Thromboembolism Incidence in Patients With Ankle Fracture: A Machine Learning Approach. Foot & Ankle Specialist. 2024. doi:10.1177/19386400231207692

BibTeX
@article{Nassour2024,
  author = {Nassour, Nour and Akhbari, Bardiya and Ranganathan, Noopur and Tawakol, Ahmed and Rosovsky, Rachel P and Guss, Daniel and DiGiovanni, Christopher W and Ashkani-Esfahani, Soheil},
  title = {Correlation Between Statin Use and Symptomatic Venous Thromboembolism Incidence in Patients With Ankle Fracture: A Machine Learning Approach},
  journal = {Foot & Ankle Specialist},
  year = {2024},
  doi = {10.1177/19386400231207692}
}
Kostenlos starten →